Xtant Medical Reports First Quarter 2024 Revenue Growth of 55% and Raises Full Year 2024 Revenue GuidanceAccesswire • 05/15/24
Xtant Medical Announces Launch of SimpliGraft™ and SimpliMax™ for Chronic and Acute WoundsGlobeNewsWire • 04/30/24
Xtant Medical to Issue Fourth Quarter and Full Year 2023 Financial Results on April 1, 2024GlobeNewsWire • 03/21/24
Xtant Medical Increases Revolving Credit Facility to $17 Million with MidCap FinancialGlobeNewsWire • 03/07/24
Xtant Medical Announces Acquisition of nanOss Production Operations from RTI SurgicalGlobeNewsWire • 10/23/23
Xtant Medical Completes Acquisition of Surgalign's Hardware and Biologics BusinessGlobeNewsWire • 08/10/23
Xtant Medical to Issue Second Quarter 2023 Financial Results on August 1, 2023GlobeNewsWire • 07/25/23
Xtant Medical Announces First Quarter 2023 Revenue Growth of 38% and Full Year 2023 Revenue GuidanceGlobeNewsWire • 05/04/23